K

KalGene Pharmaceuticals

0 followers

Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.

Industries

Headquarters

Montreal, Canada

Employees

1-10

Links

Org chart

Nickolay V. Kukekov's profile picture
Nickolay V. Kukekov
President & CEO
Profile photo

Nickolay V. Kukekov

Collapse
Albert Agro's profile picture
Albert Agro
Acting Chief Medical Officer
Guriq S. Basi's profile picture
Guriq S. Basi
Head of Preclinical Studies

Offices

  1. Something went wrong loading the org chart, please refresh the page.